BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20709526)

  • 21. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
    Ou XB; Chen XY; Wu MH; Luo WR
    Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.
    Sheu LF; Chen A; Lee HS; Hsu HY; Yu DS
    Pathol Int; 2004 Jul; 54(7):475-85. PubMed ID: 15189500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of EB virus latent membrane protein 1 on mitosis control of nasopharyngeal carcinoma cell line CNE1].
    Liu B; Chen XY
    Ai Zheng; 2004 May; 23(5):512-6. PubMed ID: 15142445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma.
    Lu ZX; Ma XQ; Yang LF; Wang ZL; Zeng L; Li ZJ; Li XN; Tang M; Yi W; Gong JP; Sun LQ; Cao Y
    Cancer Lett; 2008 Jul; 265(2):226-38. PubMed ID: 18353539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of Epstein-Barr virus latent membrane protein 1(EBV-LMP1) on related factors of metastasis of nasopharyngeal carcinoma cell line CNE1].
    Gou XM; Chen Y; Chen XY; Arrand JR
    Ai Zheng; 2003 May; 22(5):481-5. PubMed ID: 12753707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells].
    Shen ZH; Chen XY; Chen J
    Ai Zheng; 2008 Feb; 27(2):165-9. PubMed ID: 18279614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.
    Pioche-Durieu C; Keryer C; Souquère S; Bosq J; Faigle W; Loew D; Hirashima M; Nishi N; Middeldorp J; Busson P
    J Virol; 2005 Nov; 79(21):13326-37. PubMed ID: 16227255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.
    Lui VW; Wong EY; Ho Y; Hong B; Wong SC; Tao Q; Choi GC; Au TC; Ho K; Yau DM; Ma BB; Hui EP; Chan AS; Tsang CM; Tsao SW; Grandis JR; Chan AT
    Int J Cancer; 2009 Oct; 125(8):1884-93. PubMed ID: 19588483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells.
    Chen RJ; Ho YS; Guo HR; Wang YJ
    Toxicol Sci; 2008 Aug; 104(2):283-93. PubMed ID: 18448488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells.
    Xu Y; Shi Y; Yuan Q; Liu X; Yan B; Chen L; Tao Y; Cao Y
    J Exp Clin Cancer Res; 2013 Nov; 32(1):90. PubMed ID: 24499623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
    Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
    Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology.
    Yan G; Li L; Tao Y; Liu S; Liu Y; Luo W; Wu Y; Tang M; Dong Z; Cao Y
    Proteomics; 2006 Mar; 6(6):1810-21. PubMed ID: 16470631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells.
    Chang SH; Chang HC; Hung WC
    Oral Oncol; 2008 Sep; 44(9):891-7. PubMed ID: 18289921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression and relationship of EBV LMP1, COX-2 and VEGF-C in nasopharyngeal carcinoma].
    Yi X; Tang A; Qin Y; Wen W; Zhao W
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Feb; 24(3):126-8. PubMed ID: 20429385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma.
    Faqing T; Zhi H; Liqun Y; Min T; Huanhua G; Xiyun D; Ya C
    Exp Oncol; 2005 Jun; 27(2):96-101. PubMed ID: 15995625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Epstein-Barr virus (EBV)-encoded latent membrane proteins and STAT3 activation in nasopharyngeal carcinoma.
    Buettner M; Heussinger N; Niedobitek G
    Virchows Arch; 2006 Nov; 449(5):513-9. PubMed ID: 17033798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.
    Kondo S; Yoshizaki T; Wakisaka N; Horikawa T; Murono S; Jang KL; Joab I; Furukawa M; Pagano JS
    J Virol; 2007 Feb; 81(4):1554-62. PubMed ID: 17151127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LMP1 stimulates the transcription of eIF4E to promote the proliferation, migration and invasion of human nasopharyngeal carcinoma.
    Zhao Y; Pang TY; Wang Y; Wang S; Kang HX; Ding WB; Yong WW; Bie YH; Cheng XG; Zeng C; Yao YH; Li Q; Hu XR
    FEBS J; 2014 Jul; 281(13):3004-18. PubMed ID: 24814906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.
    Mao Y; Wang J; Zhang M; Fan W; Tang Q; Xiong S; Tang X; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xu L; Yin R; Zhu J
    Oncotarget; 2017 Feb; 8(7):10954-10965. PubMed ID: 28009988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.